Vaccines

Misinformation and confusion about the COVID-19 vaccines and pregnancy remains widespread, with most people – including women who are pregnant or trying to get pregnant – either believing or being uncertain about at least one of three false claims they’ve heard, a new KFF COVID-19 Vaccine Monitor shows. Among women…

In a new analysis, KFF researchers find that COVID-19 vaccination rates among nursing home staff increased by 25 percentage points nationally (63% to 88%) from when the Biden administration announced the vaccine mandate for health care workers in August 2021 to after vaccination deadlines passed in March 2022. Researchers analyzed…

This analysis uses nursing facility-level data reported by the federal government to track the increase in vaccination rates among nursing facility staff nationally and by state between August 2021 (when the vaccine mandate was first announced) and March 27th, 2022 (after the vaccine deadline for health workers had passed in all states). Additionally, this analysis provides state-level information on booster rates among nursing home staff and the prevalence of staffing shortages after all vaccination deadlines had passed.

About a Third of the Public Thinks the Nation is Facing a New COVID-19 Wave as Cases Rise About a fifth (18%) of parents with children under age 5 say they intend to get their child vaccinated “right away” once federal regulators authorize its use for their child’s age group,…

This Vaccine Monitor survey finds about one in five parents of children under age five say they will get their child vaccinated right away, and another 38% plan to wait and see how the vaccine is working for others. With mask mandates lifted in many areas. most workers say they feel safe at their workplace, though Black, Hispanic and low-income workers are less likely to feel “very safe.”

With an impasse in Congress over additional COVID-19 emergency funding, uninsured people could lose access to free testing and treatment services, a new KFF brief explains. For people without health insurance, the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program has reimbursed hospitals, doctors and other providers for the…

A current impasse in Congress threatens continued funding for COVID-19 testing, treatment, and vaccines. The lack of additional federal COVID-19 funding has broad implications for access to these services, particularly for the uninsured, and could undermine efforts to ensure equitable access to these resources.

This Vaccine Monitor survey shows the public is largely supportive of the U.S. role in distributing COVID-19 vaccines globally, as well as other response efforts including the distribution of masks and COVID-19 rapid tests.

With funding for additional COVID-19 support at a stalemate in Congress, a new KFF analysis looks at potential scenarios that United States might face if a 4th COVID-19 vaccine dose is recommended to the public. The analysis finds that the U.S. government does not have enough funding to purchase vaccine…

This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. While estimated U.S. COVID-19 vaccine supply needs vary widely depending on assumptions and how many people choose to get vaccinated, this analysis indicates that under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.